HLTH: How Silicon Valley Bank’s Julie Ebert is Transforming Healthcare with Transparency
The health tech fundraising environment shows promise. More deals are occurring alongside modest growth in total funding, suggesting a shift toward realistic valuations.
In this episode, Julie Ebert, managing director of Healthcare and Life Sciences for Silicon Valley Bank, discusses the key findings from their annual Future of Health Tech report, highlighting the growth of AI adoption in healthcare as well as the increasing focus on specialty value-based care models. She noted a third of health tech companies that have raised money have an AI component, and half of the investment is in the administrative use of AI. Julie also explains that value-based care is moving from primary care to specialties due to these areas being complex and costly. Finally, she emphasizes that Silicon Valley Bank is playing a bold role in providing transparency to companies by offering working capital solutions and releasing reports that allow companies to have the knowledge to move forward.
Tune in and learn about the current landscape of health tech investment and the future of value-based care!
About Julie Ebert:
Julie Betts Ebert is Managing Director of Silicon Valley Bank’s National Life Science & Healthcare team, supporting life science companies in the Mid-Atlantic and Southeast with banking services, debt financing, and strategic growth advice. Previously, she led SVB’s Strategic Advisory effort, managing client engagements and advisory projects. Julie’s prior experience includes 10 years at Greenhill & Co., advising on M&A and restructuring, and roles at Prudential Securities and J.P. Morgan. She holds an M.B.A. from Columbia Business School and a B.S. in finance from the University of Virginia.
Things You’ll Learn:
There's been an increase in the number of deals being made in the health tech space, signaling a positive shift in the market despite funding not growing as drastically as there's a slight uptick.
A significant portion of health tech companies, roughly a third that have raised money, are integrating AI into their products or services, demonstrating the growing importance of AI in healthcare innovation.
Silicon Valley Bank's reports aim to create transparency in the market. They give companies access to critical information about venture capital trends and investment patterns, helping to level the playing field for these companies.
The 2024 Future of Healthtech report also shows that investors are becoming more pragmatic about valuations, with fewer up rounds and an increase in flat or down rounds or deals where the terms are not disclosed at all.
By offering its insights, being creative in its financing, and supporting companies with the knowledge to help move their businesses forward, Silicon Valley Bank shows that it is a bold leader who is playing a crucial role in transforming the healthcare industry and fostering innovation.
Resources:
